Innovation Pharmaceuticals Inc (IPIX)

[TheProgressive]

Welcome Orion. The beauty of what we have in progress now at Dana Farber, what's about to take place at The University of Bologna, and what is also about to get rolling at MD Anderson is that all of these world class facilities will collectively build an impressive range of compelling data on Kevetrin's effectiveness in humans in very much the same way that KARD did so in preclinicals.

In time we will be able to start checking off K as a superior treatment for many types of solid and blood cancers, with or without radiation, and/or combined with some of the other most powerful cancer agents out there. As we work our way through these milestones, we will begin to validate different revenue streams. A billion here...a billion there....next thing you know big pharma will have to have it, and the bidding war will be under way.